国际麻醉学与复苏杂志   2023, Issue (7): 0-0
    
术后急性肾损伤有关生物标志物的研究进展
代元强, 许涛, 邓小明1()
1.海军军医大学附属长海医院
Advances of biomarkers for postoperative acute kidney injury
 全文:
摘要:

术后急性肾损伤(acute kidney injury, AKI)是较为常见的术后并发症,目前采用改善全球肾病预后组织(Kidney Disease: Improving Global Outcomes, KDIGO)指南以血肌酐(serum creatinine, SCr)和尿量为诊断标准,时效性和准确性较低。文章主要通过对目前研究明确的几种肾损伤功能性生物标志物、肾小管损伤生物标志物以及其他生物标志物进行描述,以期临床中获得早期的AKI损伤指标,知悉亚临床AKI状态,预测术后AKI分期,分辨持续性AKI,并能对长期主要肾脏不良事件及相关病死率做出准确判断。

关键词: 急性肾损伤; 生物标志物; 主要肾脏不良事件
Abstract:

Postoperative acute kidney injury (AKI) is a common postoperative complication. The current guideline of Kidney Disease: Improving Global Outcomes (KDIGO) sets serum creatinine (SCr) and urine volume as the diagnostic criteria, which have low timeliness and accuracy. By describing several functional biomarkers of renal injury, biomarkers of renal tubular injury, and other biomarkers identified in current studies, this review aims to obtain early indicators of AKI injury in clinical practice, know subclinical AKI status, predict postoperative AKI stage, and distinguish persistent AKI. In addition, it can accurately judge long‑term important renal adverse events and related mortality.

Key words: Acute kidney injure; Biomarker; Major adverse kidney events